Phase I periodontal therapy is the first in the chronologic sequence of procedures that constitute periodontal treatment. It is also referred to as cause related therapy or non-surgical periodontal therapy.
It restore alveolar bone to the level existing at the time of surgery or slightly more apical to this level. Aim is to achieve positive bony architecture.
STEPS INCLUDE:
1.VERTICAL GROOVING
2. RADICULAR BLENDING
3. FLATTENING INTERPROXIMAL BONE
4. GRADUALIZING MARGINAL BONE
PREFERRED TREATMENT FOR ONE WALLED PERIODONTAL BONE DEFECTS (HEMISEPTUM)
General principles of periodontal surgery
All surgical procedures should be carefully planned. The patient should be adequately prepared medically, psychologically, and practically for all aspects of the intervention.
Surgical periodontal procedures are usually performed in the dental office.
The following findings may indicate the need for a surgical phase of therapy:
1. Areas with irregular bony contours, deep craters, and other defects usually require surgical approach.
2. Pockets on teeth in which a complete removal of root irritants is not considered clinically possible may call for surgery. This occurs frequently in molar and premolar areas.
3. In cases of furcation involvement of grade II or III, a surgical approach ensures the removal of irritants; any necessary root resection or hemisection also requires surgical intervention.
4. Intrabony pockets on distal areas of last molars, frequently complicated by mucogingival problems, are usually unresponsive to nonsurgical methods.
5. Persistent inflammation in areas with moderate to deep pockets may require a surgical approach. In areas with shallow pockets or normal sulci, persistent inflammation may point to the presence of a mucogingival problem that needs a surgical solution.
Patient Preparation
Reevaluation after Phase I Therapy.
Almost every patient undergoes the so-called initial or preparatory phase of therapy, which basically consists of thorough scaling and root planing and removing all irritants responsible for the periodontal inflammation. These procedures (1) eliminate some lesions entirely; (2) render the tissues more firm and consistent, thus permitting a more accurate and delicate surgery; and (3) acquaint the patient with the office and the operator and assistants, thereby reducing the patient’s apprehension and fear.
Premedication
For patients who are not medically compromised, the value of administering antibiotics routinely for periodontal surgery has not been clearly demonstrated. However, some studies have reported reduced postoperative complications, including reduced pain and swelling, when antibiotics are given before periodontal surgery and continued for 4 to 7 days after surgery.
Smoking
The deleterious effect of smoking on healing of periodontal wounds has been amply documented. Patients should be clearly informed of this fact and asked to quit or stop smoking for a minimum of 3 to 4 weeks after the procedure. For patients who are unwilling to follow this advice, an alternate treatment plan that does not include more sophisticated techniques (e.g., regenerative, mucogingival, esthetic) should be considered.
Common Antibiotics : Used in periodontal therapy, easy approach for therapeut...DrUshaVyasBohra
An antibiotic is an agent that either kills or inhibits the growth of a microorganism.
The term antibiotic was first used in 1942 by Selman Waksman and his collaborators in journal articles to describe any substance produced by a microorganism that is antagonistic to the growth of other microorganisms in high dilution.[3] This definition excluded substances that kill bacteria but that are not produced by microorganisms (such as gastric juices and hydrogen peroxide). It also excluded synthetic antibacterial compounds such as the sulfonamides. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.
With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds.[4] These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. In accordance with this, many antibacterial compounds are classified on the basis of chemical/biosynthetic origin into natural, semisynthetic, and synthetic. Another classification system is based on biological activity; in this classification, antibacterials are divided into two broad groups according to their biological effect on microorganisms: Bactericidal agents kill bacteria, and bacteriostatic agents slow down or stall bacterial growth.Before the early 20th century, treatments for infections were based primarily on medicinal folklore. Mixtures with antimicrobial properties that were used in treatments of infections were described over 2000 years ago.[5] Many ancient cultures, including the ancient Egyptians and ancient Greeks, used specially selected mold and plant materials and extracts to treat infections.[6][7] More recent observations made in the laboratory of antibiosis between micro-organisms led to the discovery of natural antibacterials produced by microorganisms. Louis Pasteur observed, "if we could intervene in the antagonism observed between some bacteria, it would offer perhaps the greatest hopes for therapeutics". The term 'antibiosis', meaning "against life," was introduced by the French bacteriologist Jean Paul Vuillemin as a descriptive name of the phenomenon exhibited by these early antibacterial drugs.[9][10] Antibiosis was first described in 1877 in bacteria when Louis Pasteur and Robert Koch observed that an airborne bacillus could inhibit the growth of Bacillus anthracis. These drugs were later renamed antibiotics by Selman Waksman, an American microbiologist, in 1942. Synthetic antibiotic chemotherapy as a science and development of antibacterials began in Germany with Paul Ehrlich in the late 1880s. Ehrlich noted that certain.
Phase I periodontal therapy is the first in the chronologic sequence of procedures that constitute periodontal treatment. It is also referred to as cause related therapy or non-surgical periodontal therapy.
It restore alveolar bone to the level existing at the time of surgery or slightly more apical to this level. Aim is to achieve positive bony architecture.
STEPS INCLUDE:
1.VERTICAL GROOVING
2. RADICULAR BLENDING
3. FLATTENING INTERPROXIMAL BONE
4. GRADUALIZING MARGINAL BONE
PREFERRED TREATMENT FOR ONE WALLED PERIODONTAL BONE DEFECTS (HEMISEPTUM)
General principles of periodontal surgery
All surgical procedures should be carefully planned. The patient should be adequately prepared medically, psychologically, and practically for all aspects of the intervention.
Surgical periodontal procedures are usually performed in the dental office.
The following findings may indicate the need for a surgical phase of therapy:
1. Areas with irregular bony contours, deep craters, and other defects usually require surgical approach.
2. Pockets on teeth in which a complete removal of root irritants is not considered clinically possible may call for surgery. This occurs frequently in molar and premolar areas.
3. In cases of furcation involvement of grade II or III, a surgical approach ensures the removal of irritants; any necessary root resection or hemisection also requires surgical intervention.
4. Intrabony pockets on distal areas of last molars, frequently complicated by mucogingival problems, are usually unresponsive to nonsurgical methods.
5. Persistent inflammation in areas with moderate to deep pockets may require a surgical approach. In areas with shallow pockets or normal sulci, persistent inflammation may point to the presence of a mucogingival problem that needs a surgical solution.
Patient Preparation
Reevaluation after Phase I Therapy.
Almost every patient undergoes the so-called initial or preparatory phase of therapy, which basically consists of thorough scaling and root planing and removing all irritants responsible for the periodontal inflammation. These procedures (1) eliminate some lesions entirely; (2) render the tissues more firm and consistent, thus permitting a more accurate and delicate surgery; and (3) acquaint the patient with the office and the operator and assistants, thereby reducing the patient’s apprehension and fear.
Premedication
For patients who are not medically compromised, the value of administering antibiotics routinely for periodontal surgery has not been clearly demonstrated. However, some studies have reported reduced postoperative complications, including reduced pain and swelling, when antibiotics are given before periodontal surgery and continued for 4 to 7 days after surgery.
Smoking
The deleterious effect of smoking on healing of periodontal wounds has been amply documented. Patients should be clearly informed of this fact and asked to quit or stop smoking for a minimum of 3 to 4 weeks after the procedure. For patients who are unwilling to follow this advice, an alternate treatment plan that does not include more sophisticated techniques (e.g., regenerative, mucogingival, esthetic) should be considered.
Common Antibiotics : Used in periodontal therapy, easy approach for therapeut...DrUshaVyasBohra
An antibiotic is an agent that either kills or inhibits the growth of a microorganism.
The term antibiotic was first used in 1942 by Selman Waksman and his collaborators in journal articles to describe any substance produced by a microorganism that is antagonistic to the growth of other microorganisms in high dilution.[3] This definition excluded substances that kill bacteria but that are not produced by microorganisms (such as gastric juices and hydrogen peroxide). It also excluded synthetic antibacterial compounds such as the sulfonamides. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.
With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds.[4] These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. In accordance with this, many antibacterial compounds are classified on the basis of chemical/biosynthetic origin into natural, semisynthetic, and synthetic. Another classification system is based on biological activity; in this classification, antibacterials are divided into two broad groups according to their biological effect on microorganisms: Bactericidal agents kill bacteria, and bacteriostatic agents slow down or stall bacterial growth.Before the early 20th century, treatments for infections were based primarily on medicinal folklore. Mixtures with antimicrobial properties that were used in treatments of infections were described over 2000 years ago.[5] Many ancient cultures, including the ancient Egyptians and ancient Greeks, used specially selected mold and plant materials and extracts to treat infections.[6][7] More recent observations made in the laboratory of antibiosis between micro-organisms led to the discovery of natural antibacterials produced by microorganisms. Louis Pasteur observed, "if we could intervene in the antagonism observed between some bacteria, it would offer perhaps the greatest hopes for therapeutics". The term 'antibiosis', meaning "against life," was introduced by the French bacteriologist Jean Paul Vuillemin as a descriptive name of the phenomenon exhibited by these early antibacterial drugs.[9][10] Antibiosis was first described in 1877 in bacteria when Louis Pasteur and Robert Koch observed that an airborne bacillus could inhibit the growth of Bacillus anthracis. These drugs were later renamed antibiotics by Selman Waksman, an American microbiologist, in 1942. Synthetic antibiotic chemotherapy as a science and development of antibacterials began in Germany with Paul Ehrlich in the late 1880s. Ehrlich noted that certain.
Acute periodontal diseases are clinical conditions of rapid onset that involve the periodontium. They are characterised by discomfort or pain and infection. They require urgent attention which involves prompt diagnosis and treatment to prevent the further destruction.
For undergraduate dental students this presentation gives you the wide idea about the oral ulceration & it's causes. There causes also described though it's very easy for the reader to understand & planned how to approach the studying of ulcerations regarding the mouth. Here vesicular bullous lesions also described.
Similar to acute gingival infections-Dr. Rishi Emmatty (20)
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
3. Necrotizing Ulcerative Gingivitis
It is a microbial disease of the gingiva in the context of
an impaired host response.
It is characterized by the death and sloughing of
gingival tissue and presents with characteristic signs
and symptoms.
4. Nomenclature
Ulceromembranous gingivitis, acute necrotizing
ulcerative gingivitis, Vincent’s gingivitis, Vincent’s
gingivostomatitis, necrotizing gingivostomatitis, trench
mouth
Epidemiology & prevalence
Endemic pattern
in developing countries
0.02 to 0.08% or lesser in industrialized countries
54 to 58% in India??
More in HIV+ve patients
5. Clinical features
Classification
Acute
Subacute
NUP- When bone loss occurs
History
Sudden onset
Debilitating disease
Change in living habits, stress, poor nutrition, tobacco use
6. Oral signs
Characteristic punched out, crater like depression at
the crest of the interdental papilla
A gray pseudomembraneous slough with a linear
erythema
Spontaneous gingival hemorrhage or pronounced
bleeding on slightest stimulation
Can occur in a disease free mouths or be
superimposed on chronic gingivitis/ periodontitis
Oral hygiene is generally very poor
8. Extraoral signs and symptoms
Patients may or may not have systemic complications
Local lymphadenopathy
High fever, increased pulse rate, leucocytosis, loss of
appetite & general lassitude
9. Clinical course
Indefinite course & may progress to NUP till noma
Pindborg classified NUG into following stages:
(1) Only the tip of the interdental papilla is affected
(2) The lesion extends to marginal gingiva and causes
punched-out papilla
(3) The attached gingiva is also affected
(4) Bone is exposed
10. Horning & Cohen classified as follows
Stage 1: Necrosis of tip of interdental papilla (93%)
Stage 2: Necrosis of entire papilla (19%)
Stage 3: Necrosis till gingival margin (21%)
Stage 4: Necrosis till attached gingiva (1%)
Stage 5: Necrosis till labial or buccal mucosa (6%)
Stage 6: Necrosis till alveolar bone (1%)
Stage 7: Necrosis till skin of cheek (0%)
11.
12.
13.
14.
15.
16.
17. Histopathology
Nonspecific acute necrotizing inflammation
Surface epithelium is destroyed & replaced by fibrin, necrotic cells,
PMNs & various microorganisms
Underlying connective tissue is hyperemic with numerous engorged
capillaries & PMNs
Plasma cells & monocytes are found in deeper tissues
18. Predominately spirochetes & fusiform
bacteria
Spirochetal organisms form a light staining,
conspicuous, interlacing network
Electron microscopy classifies spirochetes
into
Small spirochetes (7 to 39%)
Medium spirochetes (43.9 to 90%)
Large spirochetes ( 0 to 20%)
Bacteriology different in HIV +ve & -ve
individuals
Trepenoma, selenomonas,
fusobacterium, melaninogenicus, P. intermedia
in HIV +ve individuals
Borrelia, Gram +ve cocci, β hemolytic
streptococci, C albicans in HIV –ve individuals
Bacterial flora
19. Relation of bacteria to Characteristic lesion
Listgarten described four zones:
Zone 1: Bacterial zone
Zone 2: Neutrophil rich zone
Zone 3: Necrotic zone
Zone 4: Zone of spirocheteal infiltration
25. Etiology
Role of bacteria
Combination of fusiform & spirocheteal organisms
Role of Host response
Local predisposing factors
Preexisting gingivitis/ periodontitis, smoking, injury to gingiva
Systemic predisposing factors
Nutritional deficiency
Diet, vitamins
Debilitating disease
HIV
Psychosomatic factors
Stress
Communicability
26. Treatment
(1) Alleviation of the acute inflammation plus
treatment of chronic disease either underlying the
acute involvement or else-where in the oral cavity
(2) Alleviation of generalized toxic symptoms such
as fever and malaise
(3) Correction of systemic conditions that contribute
to the initiation or progress of the gingival
changes.
27. Sequence of Treatment
First visit
History & examination
Pseudomembrane removed under topical anesthesia with
cotton pellets.
Area is cleansed with warm water
Superficial scaling
Rinses with hydrogen peroxide or chlorhexidine
Antibiotics & analgesics
Patient instructions
Avoid smoking & alcohol
Avoid physical exertion
Avoid brushing over the area
28. Second visit
1 to 2 days after first visit
Gentle scaling
Same instructions
Third visit
5 days after second visit
Scaling & root planing
Subsequent visits
Rechecking & scaling of the areas
30. Persistent or Recurrent Cases
Reassessment of differential
diagnosis
Underlying systemic disease
causing immunosuppression
Inadequate local therapy
Inadequate compliance
31. Primary Herpetic Gingivostomatitis
Caused by HSV- I
Common in infants & children > 6 years of age
Can occur in older individuals
Asymptomatic in many persons
No sex predilection
Persists in neuronal ganglion after primary
infection
Secondary manifestations occurs as a result of
various stimuli like sunlight, trauma, fever or
stress
32. Clinical features
Oral signs
Diffuse erythematous, shiny involvement of gingiva &
adjacent oral mucosa
Accompanied with varying degree of edema & gingival
bleeding
Discrete, spherical grey vesicles on gingiva, labial & buccal
mucosa, soft palate, pharynx, sublingual mucosa & tongue are
seen in the initial stage
They rupture & form painful small ulcers with red elevated
halo like margin & a depressed yellowish or greyish white
central area
Course of disease is limited to 7 to 10 days
Heals without scarring
33.
34.
35. Oral symptoms
Generalized soreness of the mouth
Pain is present and lesions are sensitive to touch, thermal
changes, foods
Extra oral signs
Cervical adenitis, fever (101 - 105° F), malaise
History
History of exposure to a patient
History of febrile diseases like pneumonia, meningitis,
influenza & typhoid
It also occurs in the early stages of infectious mononucleosis.
36. Histopathology
Epithelial cells are targeted
Cells shows ballooning degeneration consisting of acantholysis,
nuclear clearing & nuclear enlargement
( Tzanck cells)
Infected cells fuse & form multinucleated cells & intercellular edema
This inturn leads to the formation of intraepithelial vesicles that
ruptures & develop a secondary inflammatory response with a
fibropurulent exudate
Discrete ulcerations results from rupture of vesicles having a central
area of inflammation with a purulent exudate, surrounded by a zone
rich in blood vessels
38. Treatment
Usually self limiting disease
Rarely specific
Treatment consists of palliative measures to
make the patient comfortable, untill the disease
runs its course.
Scaling is done to reduce inflammation
Lidocaine hydrochloride mouth washes are
given before food
NSAIDS can be administered
Antibiotics is some times recommended
Copious fluid intake is necessary
Herpetic whitlow
39. Pericoronitis
Refers to inflammation of the gingiva in relation to the
crown of an incompletely erupted tooth
Occurs most commonly in the mandibular third molar
area
may be acute, subacute or chronic
40. Clinical features
Partially erupted or impacted third molars is the most
common site
There is accumulation of food and bacterial growth
between the space of tooth and overlying gingiva
Inflammatory fluid & cellular exudate increase the bulk
of the flap, which interferes with closure of mouth thus
aggravating the inflammatory process
Finally there is a markedly red, swollen, suppurating
lesion which is extremely tender with radiating pain
There is a foul taste & trismus
Swelling & lymphadenitis are seen with systemic
complications
44. Treatment
All pericoronal flaps can be removed as a preventive
measure
In acute conditions
Flush the area with warm water
Swabbing with antiseptic solution
Antibiotics are prescribed
Drainage is done in abscess
In chronic conditions
Decide whether to extract the tooth or save it
Pericoronal flap is removed by blade or electrosurgery